Today: 24 April 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Southern Copper stock drops late Monday as metals selloff hits miners; what’s next for SCCO

Southern Copper stock drops late Monday as metals selloff hits miners; what’s next for SCCO

Southern Copper Corp fell 2.8% to $145.30 late Monday, tracking a sharp selloff in metals after CME Group raised margin requirements. Spot gold dropped 4.5%, silver 9.5%, and copper 4.8%, pressuring mining stocks. About 1.1 million SCCO shares traded between $143.75 and $149.00. Investors await Fed minutes Tuesday and Southern Copper’s earnings in February.
30 December 2025
··
Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Novo Nordisk is cutting Wegovy prices in China, with local reports citing 48% reductions for the highest doses in Yunnan and Sichuan. The move comes as the company faces a 2026 patent expiry for semaglutide and rising competition from Chinese drugmakers. Novo shares fell after the China pricing news circulated. The company did not disclose exact new prices in its statement.
30 December 2025
·
Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

Analog Devices Inc shares fell 0.44% to $275.63 Monday, marking a second straight decline. The Philadelphia Semiconductor Index dropped 31.94 points to 7,178.27 as chip stocks tracked a weaker U.S. market. Investors await Federal Reserve minutes Tuesday after policymakers cut rates but signaled caution. Analog Devices last issued upbeat guidance in late November, projecting fiscal Q1 revenue above analyst estimates.
30 December 2025
···
Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead Sciences shares closed up 0.15% at $124.91 on Monday after Bernstein said new Medicaid drug-pricing rules would have limited impact on its HIV drug Biktarvy. Bernstein estimated less than $200 million in 2026 revenue impact for older HIV drugs Genvoya and Odefsey. Investors await more details from the Trump administration’s pricing rollout and Gilead’s update at the J.P. Morgan Healthcare Conference in January.
30 December 2025
·
Lockheed pitches made-in-India C-130J Super Hercules line as IAF weighs 80-plane transport buy

Lockheed pitches made-in-India C-130J Super Hercules line as IAF weighs 80-plane transport buy

Lockheed Martin has offered to set up a C-130J Super Hercules final-assembly line in India as it competes for a contract to supply up to 80 military transport aircraft. India is the only location outside the U.S. under consideration for C-130J co-production, a Lockheed executive said. Rival bids include Embraer and Airbus. Some Indian media report the air force has dropped plans for more C-130Js and is focusing on a new medium transport aircraft program.
30 December 2025
·
Amphenol stock slips in year-end tech pullback; Fed minutes and housing data loom

Amphenol stock slips in year-end tech pullback; Fed minutes and housing data loom

Amphenol shares closed down 0.4% at $136.90 Monday as tech stocks dragged U.S. markets lower in thin year-end trading. The stock traded between $135.83 and $137.59 on volume of 4.3 million shares. Amphenol will report fourth-quarter results on Jan. 28. Investors are watching upcoming U.S. economic data and Federal Reserve minutes for further direction.
30 December 2025
·······
AMAT stock ends higher in thin year-end trade as tech slips — what investors are watching next

AMAT stock ends higher in thin year-end trade as tech slips — what investors are watching next

Applied Materials shares closed up 0.44% at $263.05 Monday, near their 52-week high, as broader markets slipped and trading volume remained light. The stock outperformed peers Lam Research and KLA, which both declined. Investors remain focused on U.S. export controls affecting China sales and upcoming earnings, expected Feb. 12, 2026. After-hours, Applied Materials dipped 0.13%.
30 December 2025
·
1 … 493 494 495 496 497 … 750

Stock Market Today

  • VOO Gains 0.8% Driven by 9.7% Rise in QCOM Stock
    April 24, 2026, 1:31 PM EDT. VOO, the Vanguard S&P 500 ETF, rose 0.8% today, bolstered by a 9.7% increase in Qualcomm Inc. (QCOM) shares. Other top contributors to VOO's gain include NVIDIA (+4.7%), Amazon (+3.1%), AMD (+15.1%), and Intel (+22.5%). Despite QCOM's strong price movement, insiders have sold 40 times in the past six months without any recent purchases. Wall Street analysts maintain a positive outlook with two recent buy ratings and a median price target of $150. Investors can monitor QCOM and VOO performance and insider trades via Quiver Quantitative's dashboards.

Latest article

Charter Communications Stock Plunges After Broadband Losses Rattle Wall Street

Charter Communications Stock Plunges After Broadband Losses Rattle Wall Street

24 April 2026
Charter Communications shares fell 22% Friday after the company lost 120,000 internet customers in the first quarter, double last year’s loss and worse than analyst forecasts. Revenue slipped 1% to $13.6 billion; net income dropped to $1.16 billion. The stock traded at $187.65, down $54.13. Charter is still seeking California approval to close its $34.5 billion Cox Communications deal.
Eli Lilly’s New Weight-Loss Pill Has an Early Problem: Novo’s Head Start

Eli Lilly’s New Weight-Loss Pill Has an Early Problem: Novo’s Head Start

24 April 2026
Eli Lilly’s new oral weight-loss drug Foundayo was prescribed 3,707 times in its second week on the U.S. market, well below Novo Nordisk’s oral Wegovy, which saw 18,410 prescriptions in the same period after launch. Lilly shares fell about 4% following the data, while Novo Nordisk’s U.S. shares rose nearly 6%. Foundayo was approved by the FDA on April 1 and began shipping April 6.
Why Cheetah Net Stock Jumped Today: CTNT Deal, Heavy Volume and Dilution Risk

Why Cheetah Net Stock Jumped Today: CTNT Deal, Heavy Volume and Dilution Risk

24 April 2026
Cheetah Net Supply Chain Service Inc. shares surged Friday, trading over 2.09 billion shares after the company agreed to buy Hong Kong-based Super International Trading Limited for $4.98 million in cash. The stock rose to $0.0547, up 2.16 cents. The deal includes a $10 million annual revenue commitment from the target. Cheetah recently set up a $70 million at-the-market stock sale program.
Go toTop